CME Group Croissance future
Future contrôle des critères 1/6
CME Group devrait augmenter ses bénéfices et son chiffre d'affaires de 3.1% et de 3.4% par an respectivement. Le BPA devrait croître de de 2.9% par an. Le rendement des capitaux propres devrait être 13.4% dans 3 ans.
Informations clés
3.1%
Taux de croissance des bénéfices
2.9%
Taux de croissance du BPA
Capital Markets croissance des bénéfices | 13.9% |
Taux de croissance des recettes | 3.4% |
Rendement futur des capitaux propres | 13.4% |
Couverture par les analystes | Good |
Dernière mise à jour | 29 Oct 2024 |
Mises à jour récentes de la croissance future
Recent updates
Trade On, Cash In: Why CME Group Is My Pick For Income And Growth
Oct 27Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?
Oct 23CME Group: An Attractive Business Relatively Out Of Favor
Oct 15CME Group: An Interesting Option For Every Dividend Investor
Oct 08CME Group: Poised To Benefit From Rate Cuts; Continues To Innovate
Sep 03CME Group Has It All - Growth, Dividend Growth, And Value
Aug 26Down But Not Out: Why CME Group Remains One Of My Favorite Dividend Stocks
Aug 01CME Group Inc.'s (NASDAQ:CME) Price Is Out Of Tune With Earnings
Jul 02CME Group: FMX Market Entry Poses Real Risk
Jul 01CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
Jun 05Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance
May 25CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
May 21Gunning For CME's Golden Goose
May 01Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results
Apr 26CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty
Apr 15CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates
Mar 27CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
Mar 05CME Group Is One Of My Favorite High-Yielding Stocks Today
Feb 29CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15
Feb 20CME Group: Buying 'The House' Proves A Winning Strategy
Feb 14CME Group: Uncertainty In The World Equals Higher Revenue Growth
Feb 04Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely
Dec 27Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors
Nov 14We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation
Apr 28Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 6,543 | 3,688 | 4,007 | N/A | 11 |
12/31/2025 | 6,257 | 3,524 | 3,828 | N/A | 14 |
12/31/2024 | 6,102 | 3,442 | 3,756 | N/A | 14 |
9/30/2024 | 6,034 | 3,422 | N/A | N/A | N/A |
6/30/2024 | 5,788 | 3,262 | 3,492 | 3,571 | N/A |
3/31/2024 | 5,616 | 3,157 | 3,363 | 3,444 | N/A |
12/31/2023 | 5,569 | 3,186 | 3,377 | 3,454 | N/A |
9/30/2023 | 5,338 | 3,011 | 3,311 | 3,391 | N/A |
6/30/2023 | 5,228 | 2,942 | 3,108 | 3,192 | N/A |
3/31/2023 | 5,104 | 2,828 | 3,078 | 3,159 | N/A |
12/31/2022 | 5,009 | 2,657 | 2,966 | 3,056 | N/A |
9/30/2022 | 4,833 | 2,633 | 2,650 | 2,743 | N/A |
6/30/2022 | 4,715 | 2,889 | 2,616 | 2,717 | N/A |
3/31/2022 | 4,657 | 2,745 | 2,477 | 2,599 | N/A |
12/31/2021 | 4,690 | 2,617 | 2,275 | 2,402 | N/A |
9/30/2021 | 4,630 | 2,435 | 2,225 | 2,394 | N/A |
6/30/2021 | 4,600 | 1,920 | 1,888 | 2,074 | N/A |
3/31/2021 | 4,603 | 1,913 | 2,378 | 2,561 | N/A |
12/31/2020 | 4,884 | 2,105 | 2,518 | 2,716 | N/A |
9/30/2020 | 4,911 | 2,151 | 2,581 | 2,775 | N/A |
6/30/2020 | 5,109 | 2,375 | 3,071 | 3,274 | N/A |
3/31/2020 | 5,200 | 2,386 | 2,521 | 2,761 | N/A |
12/31/2019 | 4,868 | 2,117 | 2,427 | 2,673 | N/A |
9/30/2019 | 4,959 | 2,033 | 2,229 | 2,464 | N/A |
6/30/2019 | 4,588 | 1,808 | 2,027 | 2,236 | N/A |
3/31/2019 | 4,377 | 1,860 | 2,137 | 2,285 | N/A |
12/31/2018 | 4,309 | 1,962 | 2,324 | 2,441 | N/A |
9/30/2018 | 3,973 | 4,516 | 2,301 | 2,391 | N/A |
6/30/2018 | 3,959 | 4,413 | N/A | 2,316 | N/A |
3/31/2018 | 3,824 | 4,262 | N/A | 2,057 | N/A |
12/31/2017 | 3,645 | 4,063 | N/A | 1,751 | N/A |
9/30/2017 | 3,658 | 1,498 | N/A | 1,801 | N/A |
6/30/2017 | 3,609 | 1,662 | N/A | 1,773 | N/A |
3/31/2017 | 3,590 | 1,566 | N/A | 1,732 | N/A |
12/31/2016 | 3,595 | 1,534 | N/A | 1,732 | N/A |
9/30/2016 | 3,496 | 1,452 | N/A | 1,607 | N/A |
6/30/2016 | 3,505 | 1,340 | N/A | 1,591 | N/A |
3/31/2016 | 3,418 | 1,284 | N/A | 1,626 | N/A |
12/31/2015 | 3,327 | 1,247 | N/A | 1,533 | N/A |
9/30/2015 | 3,354 | 1,262 | N/A | 1,644 | N/A |
6/30/2015 | 3,266 | 1,192 | N/A | 1,414 | N/A |
3/31/2015 | 3,178 | 1,191 | N/A | 1,327 | N/A |
12/31/2014 | 3,113 | 1,127 | N/A | 1,291 | N/A |
9/30/2014 | 2,958 | 1,014 | N/A | 1,171 | N/A |
6/30/2014 | 2,911 | 960 | N/A | 1,066 | N/A |
3/31/2014 | 2,990 | 1,008 | N/A | 1,268 | N/A |
12/31/2013 | 2,931 | 977 | N/A | 1,281 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de CME ( 3.1% par an) est supérieure au taux d'épargne ( 2.5% ).
Bénéfices vs marché: Les bénéfices de CME ( 3.1% par an) devraient croître plus lentement que le marché US ( 15.2% par an).
Croissance élevée des bénéfices: Les bénéfices de CME devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de CME ( 3.4% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).
Croissance élevée des revenus: Le chiffre d'affaires de CME ( 3.4% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de CME devrait être faible dans 3 ans ( 13.4 %).